Catrin Hasselgren, PhD

Executive Director
Genentech
South San Francisco, California, United States

Presentation(s):

• Toxicological Assessment of Pharmaceutical Impurities (CE8)

  Sunday, November 17, 2024
  1:00 PM - 4:30 PM CT

• Introduction and Framework for Impurity Management (CE8-1)

  Sunday, November 17, 2024
  1:00 PM - 1:20 PM CT

• Assessment of Genotoxicity Prediction Using New Approach Methodologies (NAMs): A Comparative Study with In Vitro Micronucleus Assays on Small Molecule Pharmaceuticals (P408)

  Monday, November 18, 2024
  5:00 PM - 6:30 PM CT

• Managing Nonmutagenic Impurities in Pharmaceuticals: Emerging Science (S13)

  Tuesday, November 19, 2024
  2:00 PM - 5:00 PM CT

• Welcome (S13-1)

  Tuesday, November 19, 2024
  2:00 PM - 2:05 PM CT

• Analysis of Non-Mutagenic Substances in the Context of Drug Impurity Assessment—Few are Potent Toxicants (S13-6)

  Tuesday, November 19, 2024
  4:00 PM - 4:15 PM CT